If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Sales and Marketing » Strategic Alliances » Identifying and Evaluating Potential Products » Identifying Potential Products
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Knowing how to most effectively identify and evaluate potential products and how to establish decision goals for products to ensure efficiency and accountability is a necessity for any pharmaceutical company. Having a formalized selection process also improves the speed and quality of development effort. This document can help pharmaceutical companies keep the process of identifying and evaluating new products moving forward by being aware of key internal milestones. It is increasingly necessary for companies to set formal rules and processes that facilitate compound movement through the selection process from development to FDA submission. This 20-page document describes how leading pharmaceutical companies establish an integrated, systematic approach, coordinating activities and resources between different departments to move the compound through as quickly as possible.
If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.